191 related articles for article (PubMed ID: 27191122)
41. Concomitant Anticonvulsants With Bitemporal Electroconvulsive Therapy: A Randomized Controlled Trial With Clinical and Neurobiological Application.
Rakesh G; Thirthalli J; Kumar CN; Muralidharan K; Phutane VH; Gangadhar BN
J ECT; 2017 Mar; 33(1):16-21. PubMed ID: 27668943
[TBL] [Abstract][Full Text] [Related]
42. Clinical and biological predictors of response to electroconvulsive therapy (ECT): a review.
Pinna M; Manchia M; Oppo R; Scano F; Pillai G; Loche AP; Salis P; Minnai GP
Neurosci Lett; 2018 Mar; 669():32-42. PubMed ID: 27793702
[TBL] [Abstract][Full Text] [Related]
43. Genetic polymorphisms for BDNF, COMT, and APOE do not affect gait or ankle motor control in chronic stroke: A preliminary cross-sectional study.
Aljuhni R; Cleland BT; Roth S; Madhavan S
Top Stroke Rehabil; 2021 Jan; 28(1):72-80. PubMed ID: 32378476
[No Abstract] [Full Text] [Related]
44. COMT Val(158)Met and BDNF C(270)T polymorphisms in schizophrenia: a case-control study.
Galderisi S; Maj M; Kirkpatrick B; Piccardi P; Mucci A; Invernizzi G; Rossi A; Pini S; Vita A; Cassano P; Stratta P; Severino G; Del Zompo M
Schizophr Res; 2005 Feb; 73(1):27-30. PubMed ID: 15567073
[TBL] [Abstract][Full Text] [Related]
45. COMT and BDNF Gene Variants Help to Predict Alcohol Consumption in Alcohol-dependent Patients.
Klimkiewicz A; Mach A; Jakubczyk A; Klimkiewicz J; Wnorowska A; Kopera M; Fudalej S; Burmeister M; Brower K; Wojnar M
J Addict Med; 2017; 11(2):114-118. PubMed ID: 27898499
[TBL] [Abstract][Full Text] [Related]
46. Executive function performance and change in aging is predicted by apolipoprotein E, intensified by catechol-O-methyltransferase and brain-derived neurotrophic factor, and moderated by age and lifestyle.
Sapkota S; Bäckman L; Dixon RA
Neurobiol Aging; 2017 Apr; 52():81-89. PubMed ID: 28131014
[TBL] [Abstract][Full Text] [Related]
47. Electroconvulsive therapy (ECT) and aerobic exercise training (AET) increased plasma BDNF and ameliorated depressive symptoms in patients suffering from major depressive disorder.
Salehi I; Hosseini SM; Haghighi M; Jahangard L; Bajoghli H; Gerber M; Pühse U; Holsboer-Trachsler E; Brand S
J Psychiatr Res; 2016 May; 76():1-8. PubMed ID: 26859236
[TBL] [Abstract][Full Text] [Related]
48. Acute and subsequent continuation electroconvulsive therapy elevates serum BDNF levels in patients with major depression.
Vanicek T; Kranz GS; Vyssoki B; Fugger G; Komorowski A; Höflich A; Saumer G; Milovic S; Lanzenberger R; Eckert A; Kasper S; Frey R
Brain Stimul; 2019; 12(4):1041-1050. PubMed ID: 31000384
[TBL] [Abstract][Full Text] [Related]
49. An investigation of EEG, genetic and cognitive markers of treatment response to antidepressant medication in patients with major depressive disorder: a pilot study.
Spronk D; Arns M; Barnett KJ; Cooper NJ; Gordon E
J Affect Disord; 2011 Jan; 128(1-2):41-8. PubMed ID: 20619899
[TBL] [Abstract][Full Text] [Related]
50. Autobiographical Memory Specificity in Major Depression Treated With Electroconvulsive Therapy.
Jelovac A; OʼConnor S; McCarron S; McLoughlin DM
J ECT; 2016 Mar; 32(1):38-43. PubMed ID: 26252557
[TBL] [Abstract][Full Text] [Related]
51. Association study of a functional catechol-o-methyltransferase polymorphism and cognitive function in patients with dementia.
Nedić G; Borovecki F; Klepac N; Mubrin Z; Hajnsek S; Nikolac M; Muck-Seler D; Pivac N
Coll Antropol; 2011 Jan; 35 Suppl 1():79-84. PubMed ID: 21648315
[TBL] [Abstract][Full Text] [Related]
52. Electroconvulsive therapy and age: Age-related clinical features and effectiveness in treatment resistant major depressive episode.
Socci C; Medda P; Toni C; Lattanzi L; Tripodi B; Vannucchi G; Perugi G
J Affect Disord; 2018 Feb; 227():627-632. PubMed ID: 29172056
[TBL] [Abstract][Full Text] [Related]
53. Comparing effects of ketamine and thiopental administration during electroconvulsive therapy in patients with major depressive disorder: a randomized, double-blind study.
Yoosefi A; Sepehri AS; Kargar M; Akhondzadeh S; Sadeghi M; Rafei A; Alimadadi A; Ghaeli P
J ECT; 2014 Mar; 30(1):15-21. PubMed ID: 24091902
[TBL] [Abstract][Full Text] [Related]
54. The Catechol-O-methyltransferase Val(108/158)Met Genetic Polymorphism cannot be Recommended as a Biomarker for the Prediction of Venlafaxine Efficacy in Patients Treated in Psychiatric Settings.
Taranu A; Asmar KE; Colle R; Ferreri F; Polosan M; David D; Becquemont L; Corruble E; Verstuyft C
Basic Clin Pharmacol Toxicol; 2017 Nov; 121(5):435-441. PubMed ID: 28627776
[TBL] [Abstract][Full Text] [Related]
55. BDNF and COMT, but not APOE, alleles are associated with psychiatric symptoms in refractory epilepsy.
Doherty C; Hogue O; Floden DP; Altemus JB; Najm IM; Eng C; Busch RM
Epilepsy Behav; 2019 May; 94():131-136. PubMed ID: 30909076
[TBL] [Abstract][Full Text] [Related]
56. Functional polymorphisms in BDNF and COMT genes are associated with objective differences in arithmetical functioning in a sample of young adults.
González-Giraldo Y; Rojas J; Novoa P; Mueller ST; Piper BJ; Adan A; Forero DA
Neuropsychobiology; 2014; 70(3):152-7. PubMed ID: 25358337
[TBL] [Abstract][Full Text] [Related]
57. A randomized, controlled trial with 6-month follow-up of repetitive transcranial magnetic stimulation and electroconvulsive therapy for severe depression.
Eranti S; Mogg A; Pluck G; Landau S; Purvis R; Brown RG; Howard R; Knapp M; Philpot M; Rabe-Hesketh S; Romeo R; Rothwell J; Edwards D; McLoughlin DM
Am J Psychiatry; 2007 Jan; 164(1):73-81. PubMed ID: 17202547
[TBL] [Abstract][Full Text] [Related]
58. Increased plasma concentration of brain-derived neurotrophic factor with electroconvulsive therapy: a pilot study in patients with major depression.
Marano CM; Phatak P; Vemulapalli UR; Sasan A; Nalbandyan MR; Ramanujam S; Soekadar S; Demosthenous M; Regenold WT
J Clin Psychiatry; 2007 Apr; 68(4):512-7. PubMed ID: 17474805
[TBL] [Abstract][Full Text] [Related]
59. A double-blind, placebo-controlled study of the impact of galantamine on anterograde memory impairment during electroconvulsive therapy.
Matthews JD; Siefert CJ; Blais MA; Park LT; Siefert CJ; Welch CA; Dubois CM; van Nieuwenhuizen AO; Rooney KO; Seabrook RC; Durham LE; Adams HC; Fava M
J ECT; 2013 Sep; 29(3):170-8. PubMed ID: 23519225
[TBL] [Abstract][Full Text] [Related]
60. BDNF serum levels and promoter methylation of BDNF exon I, IV and VI in depressed patients receiving electroconvulsive therapy.
Kleimann A; Kotsiari A; Sperling W; Gröschl M; Heberlein A; Kahl KG; Hillemacher T; Bleich S; Kornhuber J; Frieling H
J Neural Transm (Vienna); 2015 Jun; 122(6):925-8. PubMed ID: 25387785
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
